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Introduction. Appropriate prevention of infection is a key area of research in natural oriﬁce translumenal endoscopic surgery
(NOTES), as identiﬁed by the Natural Oriﬁce Surgery Consortium for Assessment and Research (NOSCAR). Methods.Ar e v i e w
of the literature was conducted evaluating the evidence base for access oriﬁce preparation/treatment in NOTES procedures in
the context of infectious complications. Recommendations based on the Oxford Centre for Evidence-Based Medicine guidelines
were made. Results. The most robust evidence includes several experimental randomised controlled trials assessing infectious
complications in the transgastric approach to NOTES. Transvaginal procedures are long established for accessing the peritoneal
cavity following disinfection with antiseptic. Only experimental case series for transcolonic and transvesical approaches are
described.Conclusion.GradeCrecommendationrequiringnopreoperativepreparationcanbemadeforthetransgastricapproach.
Antisepticirrigationisrecommendedfortransvaginal(gradeC)NOTESaccess,asiscurrentpractice.Furtherhumantrialsneedto
be conducted to corroborate the current evidence base for transgastric closure. It is important that future trials are conducted in a
methodologicallyrobustfashion,withemphasisonclinicaloutcomesandstandardisationofenterotomyclosureandpostoperative
therapy.
1.Introduction
Natural oriﬁce translumenal endoscopic surgery (NOTES)
represents a relatively recent development in the continuing
evolution of minimal access surgery and minimally invasive
surgery. Since its ﬁrst published description in 2004 by
Kalloo [1], NOTES has amassed a growing international
body of published data dedicated to improving techniques
and assessing its long term viability. Surgical access via a
natural oriﬁce rather than through a skin incision has the
potential to oﬀer great beneﬁt over open or laparoscopic
surgery, as it theoretically involves less surgical trauma and
improved cosmetic result through absence of external scars,
also eliminating the risk of incisional herniae. In turn, this
should result in less pain, earlier return to work, and greater
patient satisfaction.
NOTES access to the peritoneal cavity has been vari-
ously described via transgastric, transcolonic, transvaginal,
and transvesical approaches. There is a lack of consensus
regarding the most appropriate approach; the transvaginal
and transgastric are the approaches currently most com-
monly reported in existing literature. It is worth noting
that the concept of colpotomy and transvaginal approach
to intraperitoneal organs is an old one, ﬁrst described
by Langenbeck in 1813 for transvaginal hysterectomy [2].
One potential disadvantage of NOTES is the more diﬃcult
sterilisation of the surgical ﬁeld, compared to topical skin
disinfection for laparoscopic or open surgery. Transgastric2 Diagnostic and Therapeutic Endoscopy
and transcolonic approaches in particular involve areas
normally populated by a multitude of physiological ﬂora
which, upon translocation into the peritoneum via NOTES
enterotomy, have the potential to cause infection, abscess
formation, and systemic sepsis. Accordingly, the Natural
Oriﬁce Surgery Consortium for Assessment and Research
(NOSCAR), a key driving body in the funding and directing
ofNOTESresearch,hasidentiﬁedthepreventionofinfection
as one of the key issues requiring further assessment and
research [3].
At present there exist a lack of consensus and a paucity of
data regarding disinfection and the prevention of infection
in NOTES, and most current NOTES, research is based
on experimentation in the porcine model. Experience of
NOTES in humans is steadily increasing, and several case
series of appendectomies via transvaginal or transgastric
approaches [4, 5] and particularly cholecystectomies [5,
6] via the transvaginal approach have been published,
building on initial experience with hybrid transabdominal
laparoscopic/NOTES procedures [7–9].
The aim of this paper was to evaluate the current
evidence base relating to the preparation or treatment of the
access route for NOTES procedures in speciﬁc relation to
postoperative infectious complications.
2. Methods
2.1. Literature Search. A review of all the published literature
on NOTES procedures reporting on infectious outcomes
of access was undertaken. A comprehensive search strat-
egy was used to identify relevant evidence according to
the inclusion and exclusion criteria speciﬁed below using
the following search terms: natural oriﬁce, transgastric,
transvaginal, transvesical, transcolonic, disinfection, infec-
tion, and NOTES. The search was broadened using the
“related articles” function. The following mesh terms were
used: “endoscopy”, “gastrointestinal”, “gastroenterostomy”,
“infection”, “disinfection”, “colpotomy”, “colotomy”, and
“gastrotomy”. The bibliographies of all publications were
manually searched for any relevant references.
The following electronic databases were searched:
PubMed, MEDLINE (Ovid); EMBASE; Google Scholar.
2.2. Endpoints. The endpoints considered for evaluation of
the evidence were: (1) route of access, (2) operative interven-
tion,(3)methodofdisinfection,and(4)infectiousoutcomes
of the intervention including method of assessment.
2.3.InclusionandExclusionCriteria. Inclusioncriteriainclu-
ded all studies considering infectious outcomes following
a NOTES procedure in human or animal subjects using
the transvaginal, transcolonic, transvesical, and transgastric
access routes. No language restrictions were considered for
review. All articles which did not refer to infectious sequelae
of NOTES were excluded. Only publications relating to the
highest level of evidence for each access route were described
in this paper. All articles were independently reviewed as to
whether they fulﬁlled the above-mentioned criteria.
Levels of evidence were assessed according to the Oxford
Centre for Evidence-Based Medicine. Levels of Evidence
guidance and recommendations were based on these levels
of evidence [10].
3. Results
A total of 22 publications were included in this paper. There
were 5 comparative studies and 17 case series as illustrated
in Tables 1 and 2. There is currently no level 1 evidence
pertaining to the most appropriate level of disinfection for
a n yN O T E Sa c c e s sr o u t e .T h em o s tr o b u s te v i d e n c ea v a i l a b l e
in the NOTES literature relates to transgastric access with
several experimental trials published.
3.1. Transgastric Approach. The transgastric approach to
NOTESisthemostcommonlyinvestigatedapproachandthe
only one to have experimental randomised controlled trials
assessing methods of infection prevention. The methods
and evaluation of these trials are rather heterogeneous.
Ramamoorthy et al. demonstrate in the rat model that
use of PPIs can be associated with a greater rate of
infection [11], in agreement with endoscopic studies in
humans which have demonstrated the potential for bacterial
overgrowth of the stomach with the use of PPIs [12].
This contrasts with the results reported by Eickhoﬀ et
al. suggesting that PPIs, as part of a “maximal therapy”
combination including systemic antibiotics, chlorhexidine,
and antibiotic orogastric irrigation, can reduce the rate of
infection and intraperitoneal bacterial load after NOTES
[13]. Giday et al. demonstrate a remarkable reduction in
infectionratesthroughuseofpovidone-iodineirrigationand
systemic antibiotics compared to control in a porcine model
of NOTES liver and ovarian biopsies [14]. In contrast to this,
McGee et al. show no signiﬁcant diﬀerence between rates
of infectious complications for transgastric peritoneoscopy
regardless of preparation. Pigs were randomised to receive
either minimal saline, high volume saline, or antibiotic
irrigation, and all 3 groups had intraperitoneal placement of
a sterile foreign body. On necropsy, abscesses and obvious
i n f e c t i o no ft h ef o r e i g nb o d yw e r es e e ni na l l3g r o u p s[ 15].
All studies used as outcome measures bacterial cultures of
peritoneal and/or gastric ﬂuid aspirates and the result of
necropsyfollowingplannedeuthanasiaoftestanimalsonday
14, except for Giday et al. who performed necropsy on day 7.
Ramamoorthy et al. and Eickhoﬀ et al. also assessed serial
serum inﬂammatory markers (white blood cell count and c-
reactive protein), ﬁnding no signiﬁcant diﬀerence between
control and trial groups.
Whilst many studies use the bacterial culturing of
intraperitoneal lavage ﬂuid as the basis of determining the
presence and severity of infection, it must be noted that
a positive culture result did not necessarily correlate with
clinical ﬁndings in many studies [17, 18].
Level 3 evidence is available in the assessment of infec-
tious complications following transgastric NOTES access.
The case-controlled study by Nau et al. compared 50
patients who underwent a laparoscopic Roux-en-Y gastric
bypass (RYGB) with endoscopic gastrotomy, with 50 patientsDiagnostic and Therapeutic Endoscopy 3
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who underwent laparoscopic guided NOTES RYGB (n =
40), or NOTES staging peritoneoscopy (n = 10), using
disinfected but not sterilised endoscopes and no stom-
ach preparation or irrigation. They report that in their
series they found evidence of gastric to peritoneum cross-
contamination (based on peritoneal aspirate cultures) in
10% of laparoscopic RYGB, 21% of NOTES RYGB, and 0%
of NOTES peritoneoscopy; however, this did not correlate
to clinical ﬁndings and did not aﬀect patient management
[17]. These ﬁndings are corroborated in a further study by
Narula et al. [18] who report a case series of 10 patients
undergoing pure NOTES transgastric peritoneoscopy with-
out prior gastric disinfection using disinfected nonsterile
equipment and no subsequent cases of clinical infection.
Similarly, Dallemagne et al. [19] report a case series of
11 hybrid transgastric NOTES/transabdominal laparoscopic
cholecystectomies in which they conﬁrm contamination of
the peritoneum postgastrotomy through peritoneal aspirate
cultures, without clinical sequelae or consequence.
3.2. Transcolonic Approach. The colon as a route of access for
NOTES presents with a greater and more diverse bacterial
ﬂora than the stomach, vagina, or bladder and as a result
a theoretically greater risk of peritonitis following a trans-
colonic procedure. Several case series have demonstrated
the feasibility of this approach for procedures including
laparoscopic cholecystectomy [20] and peritoneoscopy [21,
22]inporcinemodels.Bachmanetal.[21]comparedcolonic
irrigation with povidone-iodine and antibiotic solution with
irrigation using a quaternary ammonium solution and
report that both solutions were eﬀective at signiﬁcantly
reducing colonic ﬂora (by 93% and 90%, resp.), with no
clinical evidence of infection at necropsy in 16 swine follow-
ing transcolonic NOTES peritoneoscopy and T-tag closure.
Ryou et al. [22], in their evaluation of a prototype access and
closure device, describe disinfection using colonic irrigation
with tap water, povidone-iodine, and antibiotic solution,
with no evidence of infection of adhesions at necropsy.
For the ﬁrst report of human NOTES transanal rectal
cancer resection using transanal endoscopic microsurgery
with laparoscopic assistance, the anus and rectum were
irrigated with betadine solution only without any infectious
complications. However, it is important to note that extra-
luminal dissection was commenced below the peritoneal
reﬂection with the proximal rectum tied oﬀ using a purse-
string suture to limit contamination [23]. The potential
advantage of the transrectal route is in the relative proximity
at which the colotomy can be created which may allow
for very limited segmentation of the bowel for disinfection
[24]. The development of new devices and overtubes to
facilitate sterile transcolonic access has been reported, with
Wilhelm et al. reporting successful transcolonic deployment
of their device, good closure, and no signs of inﬂammation
or infection on necropsy [25].
3.3. Transvaginal Approach. Colpotomy and the transvaginal
approach to the intraperitoneal viscera have been performed
for almost two centuries. NOTES represents an endoscopic
extension of this technique. Disinfection of the vagina
through irrigation with antiseptic such as povidone-iodine
is known to produce good bactericidal results with great
reduction in positive vaginal bacterial cultures [26]. As a
result, the transvaginal approach for NOTES procedures
is the most reported route of access in current literature,
with larger case series already published for procedures
ranging from laparoscopic cholecystectomies [27, 28]t o
NOTES-assisted right hemicolectomies [29]. The German
NOTES registry has reported 572 hybrid NOTES procedures
carried out on human patients, primarily cholecystectomies
(448 patients) and appendicectomies (42 patients) [27].
They report a 3.3% complication rate in cholecystectomies,
which includes 1 wound infection and 1 pelvic abscess
requiring laparoscopic drainage, and 0% complications with
appendicectomies.
3.4. Transvesical Approach. Initial investigations have
demonstrated the feasibility of this approach in the
porcine model, including an initial series of transvesical
NOTES peritoneoscopy [9, 30] with no reported infectious
complications. Lima et al. [30] report a series in which
NOTES peritoneoscopy is performed following cystoscopic
incision of the bladder with no evidence of infection on
necropsy. The same group has also published further series
to include transvesical transdiaphragmatic thoracoscopy
as well combined transgastric-transvesical approaches
to cholecystectomy [31] and nephrectomy [32]. Initial
feasibility studies have also been performed in human
cadaver [33] models. A case series of 60 human patients
undergoing laparoscopic prostatectomy reported minimal
contamination of the peritoneum following cystotomy, with
positive bacterial cultures in 5 patients, however with no
clinical signiﬁcance and subsequent good recovery without
further intervention required [34].
4. Discussion
The current experimental and human evidence base is on
a whole limited and methodologically not robust enough
to allow us to draw concrete and meaningful conclusions
regarding most adequate preparation and treatment of the
access oriﬁce to prevent postoperative infectious complica-
tions.
It is obvious that evaluation of postoperative infectious
complications of NOTES access as currently described in
the literature are signiﬁcantly related to the method of
closure, and therefore studies that use diﬀerent closure
modalities have limited comparability. There is currently
no single gastrotomy closure modality supported in the
literature [27], and therefore study methodology is likely to
beheterogeneous;however,fortransvaginalandtranscolonic
access the most robust closure is likely to be suturing under
direct vision. There is evidence that transvesical access does
not require formal closure and will heal satisfactorily follow-
ing perioperative insertion of a urethral catheter [30–32].
Furthermore, there is no reliable way of detecting clinically
signiﬁcant infectious complications as positive peritoneal
cultures are not always clinically signiﬁcant. In future human
trials it is likely that evaluation will be entirely clinical as6 Diagnostic and Therapeutic Endoscopy
thereareethicalconsiderationsintakingperitonealsampling
postoperatively.
It is also not known which optimal postoperative
treatment of these viscerotomies is to avoid infectious
complications. There is no data currently available to suggest
theneedforPPIorspeciﬁcantibioticcoverfollowingNOTES
e n t e r o t o m y ,a n dt h i si sl i k e l yt oh a v ea ne ﬀect on infectious
complication rate.
For these reasons the interpretation of these data is
complex, further complicated by the lack of controlled
human trials. It is clear that for gastrotomy closure, further
trials are needed to assess various modalities of prophylaxis
on an individual basis. Furthermore, evaluation of the choice
of equipment must also be considered—is sterile equipment
required or is decontamination suﬃcient and is the use and
further development of sterile overtubes to facilitate sterile
intubationofstomachorcolonindicated?Theseresultsmust
therefore be interpreted with care. It is diﬃcult to draw
concrete conclusions, exempliﬁed by the study by Eickhoﬀ
et al. which does not diﬀerentiate between the individual
eﬀects of the various components of the transgastric trial
therapy given and the therapy package as a whole [13], or the
case-controlled study by Nau et al. which uses patients with
laparoscopic gastrotomy creation as control [17]. Despite
the often contradictory results from animal trials, human
case series may be seen as oﬀering level 4 evidence that no
disinfection or preparation is required for the transgastric
approach, suggesting a grade C recommendation that no
prophylaxis is required and that further research should
continue to compare other interventions to this as control.
As the transcolonic route presents perhaps the greatest
potential source of bacterial translocation into the peri-
toneum, further study along similar lines of investigation
as have been pursued for the transgastric route would be
desirable. As well, the shorter route of access, compared to
thetraversingoforopharynxandoesophagusfortransgastric
access, may mean that the further development of sterile
o v e r t u b ed e v i c e sa sw e l la si n s t r u m e n t a t i o nt oi s o l a t e
individual colonic segments for disinfection will emerge as
feasibleandthemosteﬃcientwayforward.Currentevidence
is based on animal models, and no formal recommendation
can be made to recommend antiseptic irrigation for trans-
colonic NOTES. It is logical; however, due to the nature of
the cavity that some method of disinfection is going to be
necessary for this approach.
Although the transvaginal approach does not have any
high level evidence supporting the most appropriate method
of disinfection of the vagina preoperatively, there are large
case series in the gynaecological literature which indicate
that postoperative complication rates of colpotomy for tubal
ligation using preoperative vaginal disinfection result in a
<2% risk of infection [32, 35]. Evidence suggests that there
is therefore no infectious diﬀerence between colpotomy and
laparoscopic approaches for tubal ligation when the vagina
is disinfected using conventional topical preparations [36].
Although there are no comparisons to control, it is generally
accepted that colpotomy following disinfection of the vagina
using sterile instrumentation is associated with a low and
acceptable risk of bacterial contamination of the peritoneal
cavity.Infectiouscomplicationsareofcoursealtereddepend-
ing on the operative intervention; however, it is presumed
that this risk is not dependent on preparation of the vagina.
The transvaginal approach to NOTES, as a laparoscopic
extrapolation of existing techniques, shows good experimen-
tal evidence of its feasibility [27, 34]. We recommend anti-
septic disinfection of the vagina in accordance with current
practice (grade C recommendation, based on consistent case
series). There is no current evidence suggesting preferential
use of either povodine-iodine or chlorhexidine.
As the urinary tract is under normal circumstances
sterile, theoretically no special preparation is required for
the transvesical approach. The study by McGee et al. [34]
suggests that the transvesical approach is a viable option
for clean access to the peritoneum requiring minimal
disinfection or prophylaxis. Transvesical NOTES has yet
to be performed in humans, with limited animal study-
based evidence. Current experimental evidence suggests that
cystotomy should be possible without speciﬁc disinfection or
systemic prophylaxis (grade D recommendation).
It is important that further evaluation is conducted
in a methodologically appropriate fashion. This involves
speciﬁc comparisons of individual treatments/preparations
of the oriﬁce, using a standardized and identical closure
modality, with objective evaluation of infectious sequelae
in blinded randomised controlled trials. The results of this
paper suggest that there is still a lack of experimental
evidence pertaining to transrectal or transvesical access to
justify implementation of human trials. Further animal
evaluation is necessary for the transrectal route; however,
due to the sterility of the urinary tract, it seems logical that
eﬀorts need to focus on disinfecting the external urethral
oriﬁce and surrounding areas which come into contact with
operative instrumentation or the use of a sterile overtube to
aid deployment of instrumentation. Due to the diameter of
the urethra, current human application of this natural oriﬁce
approach has been limited.
Based on the results of this paper, we suggest that it is
appropriate to embark on human randomised controlled tri-
als in the assessment of infectious complications of transgas-
tric access. The operative intervention must be appropriate
and safe, which will likely involve a hybrid approach with
closure of the gastrotomy performed laparoscopically. Out-
come measures have to be objective and clinically relevant,
and the levels of disinfection/sterilisation of the transgastric
instrumentation or overtubes have to be standardised and
clearly described as well as the postoperative treatment.
As with all NOTES research, it is of vital importance that
trials are carried out under IRB-approved protocols and that
favourable as well as unfavourable results are disseminated
through expedient publication in peer-reviewed journals as
well as established NOTES registries.
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